Business

Issue of Equity and TVR

Issue of Equity and TVR.

articleOndine Biomedical, Inc.August 21, 20233/company/ondine-biomedical-inc/news/issue-of-equity-and-tvr-11
Issue of Equity and TVR

About this update from Ondine Biomedical, Inc.

[{"type":"text","content":"\n\n21 August 2023\nONDINE BIOMEDICAL INC.\n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\nIssue of Equity & Total Voting Rights\nOndine Biomedical Inc. (AIM: OBI) announces the issue of 78,719 common shares in the Company (\"Common Shares\") pursuant to an annual bonus award for a staff member. The Common Shares are being issued at a price of $0.212 USD* per Common Share.\n \nAdmission and Total Voting Rights\nApplication is being made for the admission to trading on AIM (\"Admission\") of the 78,719 Common Shares, which will rank pari passu in all respects with the Company's existing common shares. Admission of the Common Shares is expected to become effective on 23 August 2023.\nFollowing Admission, the total number of Common Shares in the Company with voting rights will be 195,062,126. The Company does not hold any shares in Treasury. The above figure of 195,062,126 Common Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.\n* Based on the Company's closing share price, and GBP/USD exchange rate, on 27 March 2023 being the reference date for the bonus award. \n\n\n\nOndine Biomedical Inc.       \n\n\n \n\n\n\n\nAngelika Vance, Corporate Communications\n\n\n+001 (1) 604 838 2702\n\n\n\n\n \n\n\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser and Joint Broker)\n\n\n \n\n\n\n\nAubrey Powell, Asha Chotai, Sam Butcher                                                 \n\n\n+44 (0)20 7496 3000\n\n\n\n\n \n\n\n \n\n\n\n\nRBC Capital Markets (Joint Broker)\n\n\n \n\n\n\n\nRupert Walford, Kathryn Deegan\n\n\n+44 (0) 20 7653 4000\n\n\n\n\n \n\n\n \n\n\n\n\nVane Percy & Roberts (Media Contact)\n\n\n \n\n\n\n\nSimon Vane Percy, Amanda Bernard\n\n\n+44 (0) 77 1000 5910\n\n\n\n \nAbout Ondine Biomedical Inc.\nOndine Biomedical Inc. is a Canadian headquartered company innovating in the field of ...

More updates from Ondine Biomedical, Inc.